Sangamo Biosciences sponsored Keystone Symposia starts April 26th

Mechanisms of HIV Persistence: Implications for a Cure

Scientific Organizers: Olivier Lambotte, Steven G. Deeks and Guido Silvestri

April 26—May 1, 2015

Boston Park Plaza, Boston, Massachusetts, USA

Sponsored by Bristol-Myers Squibb Company, Gilead Sciences, Inc., Merck & Co., Inc.
and Sangamo BioSciences, Inc. Part of the Keystone Symposia Global Health Series,
supported by the Bill & Melinda Gates Foundation.

Steven G. Deeks, UCSF Medical School, provided advice for the Sangamo HIV CCR5 trials.

Paula M. Cannon, University of Southern California, Keck School of Medicine, USA
Targeted Nuclease Approaches for a Functional Cure (Sangamo Investigator)

Joumana Zeidan, Case Western Reserve University, USA
Short Talk: Decay of the HIV Reservoir Post Autologous Transfer of ZFN CCR5 Modified CD4 T Cells (SB-728-T) Correlates with Generation of a T Memory Stem Cell-Like Population and Enhanced HIV-Specific CD8 T Cell Polyfunctionality (Sangamo Investigator)